Cite
HARVARD Citation
Rencz, F. et al. (2017). Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe. Expert review of pharmacoeconomics & outcomes research. pp. 597-606. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rencz, F. et al. (2017). Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe. Expert review of pharmacoeconomics & outcomes research. pp. 597-606. [Online].